Resultats de la cerca - Yearley, Jennifer

Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high fat/high cholesterol diet per Yearley, Jennifer H., Xia, Dongling, Pearson, Christine, Carville, Angela, Shannon, Richard P., Mansfield, Keith G.

Obtenir text complet Obtenir text complet Obtenir text complet

Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma per Owen, Dwight, Chu, Benjamin, Lehman, Amy M., Annamalai, Lakshmanan, Yearley, Jennifer H., Shilo, Konstantin, Otterson, Gregory A.

Obtenir text complet Obtenir text complet Obtenir text complet

Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma per Tarhini, Ahmad A., Zahoor, Haris, Yearley, Jennifer H., Gibson, Christopher, Rahman, Zahra, Dubner, Rachel, Rao, Uma N. M., Sander, Cindy, Kirkwood, John M.

Obtenir text complet Obtenir text complet Obtenir text complet

High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease per Nota, Sjoerd P. F. T., Al-Sukaini, Ahmad, Patel, Shalin S., Sabbatino, Francesco, Nielsen, G. Petur, Deshpande, Vikram, Yearley, Jennifer H., Ferrone, Soldano, Wang, Xinhui, Schwab, Joseph H.

Obtenir text complet Obtenir text complet Obtenir text complet

Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study per Shui, Irene M., Liu, Xiao Qiao, Zhao, Qing, Kim, Seung Tae, Sun, Yuan, Yearley, Jennifer H., Choudhury, Tasmiah, Webber, Andrea L., Krepler, Clemens, Cristescu, Razvan, Lee, Jeeyun

Obtenir text complet Obtenir text complet Obtenir text complet

Immune phenotype of patients with stage IV metastatic inflammatory breast cancer per Fernandez, Sandra V., MacFarlane, Alexander W., Jillab, Mowafaq, Arisi, Maria F., Yearley, Jennifer, Annamalai, Lakshmanan, Gong, Yulan, Cai, Kathy Q., Alpaugh, R. Katherine, Cristofanilli, Massimo, Campbell, Kerry S.

Obtenir text complet Obtenir text complet Obtenir text complet

Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions per Bauché, David, Mauze, Smita, Kochel, Christina, Grein, Jeff, Sawant, Anandi, Zybina, Yulia, Blumenschein, Wendy, Yang, Peng, Annamalai, Lakshmanan, Yearley, Jennifer H, Punnonen, Juha, Bowman, Edward P, Chackerian, Alissa, Laface, Drake

Obtenir text complet Obtenir text complet Obtenir text complet

IMMU-11. AN ANALYSIS OF IMMUNOPHENOTYPE, INCLUDING PD-L1 AND PD1 EXPRESSION, IN PEDIATRIC CNS MALIGNANCIES: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY per Hwang, Eugene, Yang, Changling, Onar-Thomas, Arzu, Fangusaro, Jason, Gururangan, Sridharan, Yearley, Jennifer, Blumenschein, Wendy, McClanahan, Terri, Annamalai, Lakshman, Kocak, Mehmet, Partap, Sonia, Hummel, Trent, Dunkel, Ira, Fouladi, Maryam, Mitchell, Duane

Obtenir text complet Obtenir text complet

The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers per Barrett, Michael T., Lenkiewicz, Elizabeth, Malasi, Smriti, Basu, Anamika, Yearley, Jennifer Holmes, Annamalai, Lakshmanan, McCullough, Ann E., Kosiorek, Heidi E., Narang, Pooja, Wilson Sayres, Melissa A., Chen, Meixuan, Anderson, Karen S., Pockaj, Barbara A.

Obtenir text complet Obtenir text complet Obtenir text complet

Differential immune microenvironments and response to immune checkpoint blockade amongst molecular subtypes of murine medulloblastoma per Pham, Christina D., Flores, Catherine, Yang, Changlin, Pinheiro, Elaine M., Yearley, Jennifer H., Sayour, Elias J., Pei, Yanxin, Moore, Colin, McLendon, Roger E., Huang, Jianping, Sampson, John H., Wechsler-Reya, Robert, Mitchell, Duane A.

Obtenir text complet Obtenir text complet Obtenir text complet

IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade per Ayers, Mark, Lunceford, Jared, Nebozhyn, Michael, Murphy, Erin, Loboda, Andrey, Kaufman, David R., Albright, Andrew, Cheng, Jonathan D., Kang, S. Peter, Shankaran, Veena, Piha-Paul, Sarina A., Yearley, Jennifer, Seiwert, Tanguy Y., Ribas, Antoni, McClanahan, Terrill K.

Obtenir text complet Obtenir text complet Obtenir text complet

Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE) per Chandramouleeswaran, Prasanna M., Shen, Dawen, Lee, Anna J., Benitez, Alain, Dods, Kara, Gambanga, Fiona, Wilkins, Benjamin J., Merves, Jamie, Noah, Yuliana, Toltzis, Sarit, Yearley, Jennifer H., Spergel, Jonathan M., Nakagawa, Hiroshi, Malefyt, Rene deWaal, Muir, Amanda B., Wang, Mei-Lun

Obtenir text complet Obtenir text complet Obtenir text complet

CTIM-32. PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS per Reardon, David, Molinaro, Annette, Peters, Katherine, Clarke, Jennifer, Jordan, Justin, de Groot, John, Nghiemphu, Phioanh, Kaley, Thomas, Colman, Howard, McCluskey, Christine, Smith, Timothy, Cote, David, Severgnini, Mariano, Yearley, Jennifer, Zhao, Qing, Blumenschein, Wendy, Duda, Gabriel, Muzikansky, Alona, Jain, Rakesh, Wen, Patrick, Nayak, Lakshmi

Obtenir text complet Obtenir text complet

NCOG-44. NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA per Nayak, Lakshmi, Molinaro, Annette, Peters, Katherine, Clarke, Jennifer, Jordan, Justin, de Groot, John, Nghiemphu, Phioanh, Kaley, Thomas, Colman, Howard, McCluskey, Christine, Gaffey, Sarah, Smith, Timothy, Cote, David, Severgnini, Mariano, Yearley, Jennifer, Zhao, Qing, Blumenschein, Wendy, Duda, Gabriel, Muzikansky, Alona, Jain, Rakesh, Wen, Patrick, Reardon, David

Obtenir text complet Obtenir text complet

PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma per Sabbatino, Francesco, Villani, Vincenzo, Yearley, Jennifer H., Deshpande, Vikram, Cai, Lei, Konstantinidis, Ioannis T., Moon, Christina, Nota, Sjoerd, Wang, Yangyang, Al-Sukaini, Ahmad, Zhu, Andrew X., Goyal, Lipika, Ting, David T., Bardeesy, Nabeel, Hong, Theodore S., Castillo, Carlos Fernandez-del, Tanabe, Kenneth K., Lillemoe, Keith D., Ferrone, Soldano, Ferrone, Cristina R.

Obtenir text complet Obtenir text complet Obtenir text complet

A PILOT AND FEASIBILITY CLINICAL TRIAL EVALUATING IMMUNO-GENE THERAPY OF MALIGNANT PLEURAL MESOTHELIOMA (MPM) USING INTRAPLEURAL DELIVERY OF ADENOVIRUS- INTERFERON-ALPHA (Ad.hIFN-α... per Sterman, Daniel H, Alley, Evan, Stevenson, James, Friedberg, Joseph, Metzger, Susan, Recio, Adri, Moon, Edmund, Haas, Andrew R, Vachani, Anil, Katz, Sharyn I, Sun, Jing, Heitjan, Daniel F, Hwang, Wei-Ting, Litzky, Leslie, Yearley, Jennifer H, Tan, Kay See, Papasavvas, Emmanouil, Kennedy, Paul, Montaner, Luis J., Cengel, Keith, Simone, Charles B, Culligan, Melissa, Langer, Corey J, Albelda, Steven M

Obtenir text complet Obtenir text complet Obtenir text complet

Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy per Cristescu, Razvan, Mogg, Robin, Ayers, Mark, Albright, Andrew, Murphy, Erin, Yearley, Jennifer, Sher, Xinwei, Liu, Xiao Qiao, Lu, Hongchao, Nebozhyn, Michael, Zhang, Chunsheng, Lunceford, Jared K., Joe, Andrew, Cheng, Jonathan, Webber, Andrea L., Ibrahim, Nageatte, Plimack, Elizabeth R., Ott, Patrick A., Seiwert, Tanguy Y., Ribas, Antoni, McClanahan, Terrill K., Tomassini, Joanne E., Loboda, Andrey, Kaufman, David

Obtenir text complet Obtenir text complet Obtenir text complet

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma per Nayak, Lakshmi, Molinaro, Annette M., Peters, Katherine, Clarke, Jennifer L., Jordan, Justin T., de Groot, John, Nghiemphu, Leia, Kaley, Thomas, Colman, Howard, McCluskey, Christine, Gaffey, Sarah, Smith, Timothy R., Cote, David J., Severgnini, Mariano, Yearley, Jennifer H., Zhao, Qing, Blumenschein, Wendy M., Duda, Dan G., Muzikansky, Alona, Jain, Rakesh K., Wen, Patrick Y., Reardon, David A.

Obtenir text complet Obtenir text complet Obtenir text complet

PD-1 blockade induces responses by inhibiting adaptive immune resistance per Tumeh, Paul C., Harview, Christina L., Yearley, Jennifer H., Shintaku, I. Peter, Taylor, Emma J. M., Robert, Lidia, Chmielowski, Bartosz, Spasic, Marko, Henry, Gina, Ciobanu, Voicu, West, Alisha N., Carmona, Manuel, Kivork, Christine, Seja, Elizabeth, Cherry, Grace, Gutierrez, Antonio, Grogan, Tristan R., Mateus, Christine, Tomasic, Gorana, Glaspy, John A., Emerson, Ryan O., Robins, Harlan, Pierce, Robert H., Elashoff, David A., Robert, Caroline, Ribas, Antoni

Obtenir text complet Obtenir text complet Obtenir text complet

T‐cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death‐ligand 1 expression in patients with soft tissue sarcomas per Pollack, Seth M., He, Qianchuan, Yearley, Jennifer H., Emerson, Ryan, Vignali, Marissa, Zhang, Yuzheng, Redman, Mary W., Baker, Kelsey K., Cooper, Sara, Donahue, Bailey, Loggers, Elizabeth T., Cranmer, Lee D., Spraker, Matthew B., Seo, Y. David, Pillarisetty, Venu G., Ricciotti, Robert W., Hoch, Benjamin L., McClanahan, Terrill K., Murphy, Erin, Blumenschein, Wendy M., Townson, Steven M., Benzeno, Sharon, Riddell, Stanley R., Jones, Robin L.

Obtenir text complet Obtenir text complet Obtenir text complet